These outcomes, together with a preceding report showing that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like habits in mice,two assistance the idea of targeting ACKR3 as a unique method to modulate the opioid process, which could open up new therapeutic avenues for opioid-similar